Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
Abstract
DLL3 is overexpressed in neuroendocrine prostate cancer and is a potential therapeutic target.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Mar 20, 2019
- Source ID
- 10.1126/scitranslmed.aav0891
Entities
People
- Adam J Donoghue
- Andrea Sboner
- Aram Vosoughi
- David M. Nanus
- David Rickman
- Etienne Dardenne
- Heng Pan
- Himisha Beltran
- Juan Miguel Mosquera
- Judy Hess
- Kaitlyn Gayvert
- Kumiko Isse
- Laura Saunders
- Loredana Puca
- Luisa Fernandez
- Megan Slade
- Michael Sigouros
- Olivier Elemento
- Ryan Dittamore
- Samaneh Motanagh
- Scott T Tagawa
- Verena Sailer
- Vincenza Conteduca
- Yuzhuo Wang
Organizations
- Epic Sciences
- Harvard Medical School
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
- Prostate Cancer Foundation
- United States Department of Defense
- University of British Columbia
- Weill Cornell Medicine